The Bridge at three weeks: early lessons from the launch
Published 2026-07-21
Medicare's GLP-1 Bridge took effect July 1, 2026, opening $50/month access to Wegovy, Zepbound (KwikPen), and Foundayo for eligible Part D enrollees. Three weeks in, a consistent picture of early friction has emerged — none of it fatal, all of it navigable with preparation.
The most common stumble is at the pharmacy counter: claims that route to the patient's Part D plan instead of the program's central processor, producing wildly wrong price quotes. The fix is asking the pharmacist to process the fill under the Bridge specifically — our troubleshooting guide walks through the exact questions. Second is the Zepbound form rule: only KwikPens process under the program, and prescriptions written without specifying the form are bouncing. Third, and most painful: Extra Help enrollees learning the $50 applies to them in full, since the Low-Income Subsidy doesn't operate outside Part D.
The eligibility machinery itself appears to be functioning — prior authorizations documenting the three tiers are moving through the central processor, and the routing rules (diabetes, moderate-to-severe sleep apnea, and MASH to standard Part D) are working as designed. For anyone starting now, the playbook is unchanged: check your likely tier, prepare documentation for one provider visit, and know the KwikPen rule before your first fill.